Experienced global leader Takafumi Horii explains the rationale behind returning to his home nation of Japan to head up Takeda’s Japan Oncology operations. Horii also touches on the significant burden of cancer in Japan, how Takeda’s solutions help meet some of the country’s most significant unmet cancer needs, as well as the access challenges that the company – a relative newcomer in the oncology field – is currently facing.
Step-by-step, we are increasing the presence and engagement of Takeda Oncology Japan, leveraging the strength of our other therapeutic area business units, and stakeholders are increasingly recognising the value that we bring.
